GenomeMe specializes in in-vitro companion diagnostic test development and services. Our facility is MDSAP/ISO13485:2016 accredited to meet your most challenging clinical trial requirements. With our proprietary mAb technology, we are the first and only institution globally to develop each of the 260+ clinical IHC antibodies currently used in hospital worldwide, including the most technically demanding PD-L1 Abs for different companion CDx tests. We are also leading in recombinant AAV and lentivirus, providing in vivo grade viruses for animal testing in various gene and immunotherapy programs.